05.26.21 -- How Takeda Is Expanding Its Real-World Data Through A Global Myeloma Trial
05.26.21 -- How Takeda Is Expanding Its Real-World Data Through A Global Myeloma Trial Combining drugs that may have been shelved with established, safe, and approved drugs has the potential to bring safer, effective therapies to patients. Attend this webinar to learn more about key trends, understanding technical challenges, and shortening timelines by smart working in parallel for scale-up and late-phase development. Click here to register. Featured Editorial By Dawn Marie Stull, Takeda Oncology There is more focus than ever before on tailoring treatm...
Source: clinicalleader.com